List of Tables
    Table 1. Still's Disease Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Still's Disease Treatment Market Trends
    Table 3. Still's Disease Treatment Market Drivers
    Table 4. Still's Disease Treatment Market Challenges
    Table 5. Still's Disease Treatment Market Restraints
    Table 6. Global Still's Disease Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Still's Disease Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Still's Disease Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Still's Disease Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Still's Disease Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Still's Disease Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Still's Disease Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Still's Disease Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Still's Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Still's Disease Treatment as of 2021)
    Table 15. Top Players of Still's Disease Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Still's Disease Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Still's Disease Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Still's Disease Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Still's Disease Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Still's Disease Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Still's Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Still's Disease Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Still's Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Still's Disease Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Still's Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Still's Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Still's Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Biocon Limited Company Details
    Table 31. Biocon Limited Business Overview
    Table 32. Biocon Limited Still's Disease Treatment Product
    Table 33. Biocon Limited Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million)
    Table 34. Biocon Limited Recent Development
    Table 35. Epirus Biopharmaceuticals, Inc. Company Details
    Table 36. Epirus Biopharmaceuticals, Inc. Business Overview
    Table 37. Epirus Biopharmaceuticals, Inc. Still's Disease Treatment Product
    Table 38. Epirus Biopharmaceuticals, Inc. Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million)
    Table 39. Epirus Biopharmaceuticals, Inc. Recent Development
    Table 40. Genor BioPharma Co., Ltd. Company Details
    Table 41. Genor BioPharma Co., Ltd. Business Overview
    Table 42. Genor BioPharma Co., Ltd. Still's Disease Treatment Product
    Table 43. Genor BioPharma Co., Ltd. Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million)
    Table 44. Genor BioPharma Co., Ltd. Recent Development
    Table 45. Hetero Drugs Limited Company Details
    Table 46. Hetero Drugs Limited Business Overview
    Table 47. Hetero Drugs Limited Still's Disease Treatment Product
    Table 48. Hetero Drugs Limited Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million)
    Table 49. Hetero Drugs Limited Recent Development
    Table 50. Mabion SA Company Details
    Table 51. Mabion SA Business Overview
    Table 52. Mabion SA Still's Disease Treatment Product
    Table 53. Mabion SA Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million)
    Table 54. Mabion SA Recent Development
    Table 55. Mycenax Biotech Inc. Company Details
    Table 56. Mycenax Biotech Inc. Business Overview
    Table 57. Mycenax Biotech Inc. Still's Disease Treatment Product
    Table 58. Mycenax Biotech Inc. Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million)
    Table 59. Mycenax Biotech Inc. Recent Development
    Table 60. Oncobiologics, Inc. Company Details
    Table 61. Oncobiologics, Inc. Business Overview
    Table 62. Oncobiologics, Inc. Still's Disease Treatment Product
    Table 63. Oncobiologics, Inc. Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million)
    Table 64. Oncobiologics, Inc. Recent Development
    Table 65. Oncodesign SA Company Details
    Table 66. Oncodesign SA Business Overview
    Table 67. Oncodesign SA Still's Disease Treatment Product
    Table 68. Oncodesign SA Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million)
    Table 69. Oncodesign SA Recent Development
    Table 70. Panacea Biotec Limited Company Details
    Table 71. Panacea Biotec Limited Business Overview
    Table 72. Panacea Biotec Limited Still's Disease Treatment Product
    Table 73. Panacea Biotec Limited Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million)
    Table 74. Panacea Biotec Limited Recent Development
    Table 75. Pfizer Inc. Company Details
    Table 76. Pfizer Inc. Business Overview
    Table 77. Pfizer Inc. Still's Disease Treatment Product
    Table 78. Pfizer Inc. Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million)
    Table 79. Pfizer Inc. Recent Development
    Table 80. Sandoz International GmbH Company Details
    Table 81. Sandoz International GmbH Business Overview
    Table 82. Sandoz International GmbH Still's Disease Treatment Product
    Table 83. Sandoz International GmbH Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million)
    Table 84. Sandoz International GmbH Recent Development
    Table 85. Swedish Orphan Biovitrum AB Company Details
    Table 86. Swedish Orphan Biovitrum AB Business Overview
    Table 87. Swedish Orphan Biovitrum AB Still's Disease Treatment Product
    Table 88. Swedish Orphan Biovitrum AB Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million)
    Table 89. Swedish Orphan Biovitrum AB Recent Development
    Table 90. Therapeutic Proteins International, LLC Company Details
    Table 91. Therapeutic Proteins International, LLC Business Overview
    Table 92. Therapeutic Proteins International, LLC Still's Disease Treatment Product
    Table 93. Therapeutic Proteins International, LLC Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million)
    Table 94. Therapeutic Proteins International, LLC Recent Development
    Table 95. UCB S.A. Company Details
    Table 96. UCB S.A. Business Overview
    Table 97. UCB S.A. Still's Disease Treatment Product
    Table 98. UCB S.A. Revenue in Still's Disease Treatment Business (2017-2022) & (US$ Million)
    Table 99. UCB S.A. Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Still's Disease Treatment Product Picture
    Figure 2. Global Still's Disease Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Still's Disease Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Still's Disease Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Still's Disease Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Still's Disease Treatment Market Share in Global 2017-2028
    Figure 7. Still's Disease Treatment Report Years Considered
    Figure 8. Product Picture of Certolizumab Pegol
    Figure 9. Product Picture of DNX-514
    Figure 10. Product Picture of Etanercept
    Figure 11. Product Picture of Others
    Figure 12. Global Still's Disease Treatment Market Share by Type in 2022 & 2028
    Figure 13. Global Still's Disease Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Still's Disease Treatment Market Share by Type (2017-2028)
    Figure 15. United States Still's Disease Treatment Market Share by Type in 2022 & 2028
    Figure 16. United States Still's Disease Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Still's Disease Treatment Market Share by Type (2017-2028)
    Figure 18. Product Picture of Clinic
    Figure 19. Product Picture of Hospital
    Figure 20. Product Picture of Others
    Figure 21. Global Still's Disease Treatment Market Share by Application in 2022 & 2028
    Figure 22. Global Still's Disease Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Still's Disease Treatment Market Share by Application (2017-2028)
    Figure 24. United States Still's Disease Treatment Market Share by Application in 2022 & 2028
    Figure 25. United States Still's Disease Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Still's Disease Treatment Market Share by Application (2017-2028)
    Figure 27. North America Still's Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Still's Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Still's Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Still's Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Still's Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Still's Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Biocon Limited Revenue Growth Rate in Still's Disease Treatment Business (2017-2022)
    Figure 56. Epirus Biopharmaceuticals, Inc. Revenue Growth Rate in Still's Disease Treatment Business (2017-2022)
    Figure 57. Genor BioPharma Co., Ltd. Revenue Growth Rate in Still's Disease Treatment Business (2017-2022)
    Figure 58. Hetero Drugs Limited Revenue Growth Rate in Still's Disease Treatment Business (2017-2022)
    Figure 59. Mabion SA Revenue Growth Rate in Still's Disease Treatment Business (2017-2022)
    Figure 60. Mycenax Biotech Inc. Revenue Growth Rate in Still's Disease Treatment Business (2017-2022)
    Figure 61. Oncobiologics, Inc. Revenue Growth Rate in Still's Disease Treatment Business (2017-2022)
    Figure 62. Oncodesign SA Revenue Growth Rate in Still's Disease Treatment Business (2017-2022)
    Figure 63. Panacea Biotec Limited Revenue Growth Rate in Still's Disease Treatment Business (2017-2022)
    Figure 64. Pfizer Inc. Revenue Growth Rate in Still's Disease Treatment Business (2017-2022)
    Figure 65. Sandoz International GmbH Revenue Growth Rate in Still's Disease Treatment Business (2017-2022)
    Figure 66. Swedish Orphan Biovitrum AB Revenue Growth Rate in Still's Disease Treatment Business (2017-2022)
    Figure 67. Therapeutic Proteins International, LLC Revenue Growth Rate in Still's Disease Treatment Business (2017-2022)
    Figure 68. UCB S.A. Revenue Growth Rate in Still's Disease Treatment Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed